U.S., Jan. 30 -- ClinicalTrials.gov registry received information related to the study (NCT06799741) titled 'A Study to Evaluate the Safety and Efficacy of AV-1 Against Dengue Virus 3 (DENV-3) Infection' on Jan. 24.
Brief Summary: The goal of this clinical trial is to determine the prophylactic and therapeutic effect of AV-1 in healthy adults using a DENV-3 controlled human infection model (CHIM)
Study Start Date: Jan. 07
Study Type: INTERVENTIONAL
Condition:
DENV-3 Controlled Human Infection Model
Intervention:
DRUG: AV-1 100 mg
human monoclonal antibody (mAb) intravenous solution
or
DRUG: AV-1 300 mg
human monoclonal antibody (mAb) intravenous solution
or
DRUG: AV-1 900 mg
human monoclonal antibody (mAb) intravenous solution...